Titan Bio-Tech [TITANBIO] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison

Titan Bio-Tech

BSE
Loading...

Panacea Biotec

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Titan Bio-Tech wins in 11 metrics, Panacea Biotec wins in 7 metrics, with 0 ties. Titan Bio-Tech appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTitan Bio-TechPanacea BiotecBetter
P/E Ratio (TTM)35.79215.59Titan Bio-Tech
Price-to-Book Ratio5.132.93Panacea Biotec
Debt-to-Equity Ratio1.822.67Titan Bio-Tech
PEG Ratio4.99-1.72Panacea Biotec
EV/EBITDA30.03-188.13Panacea Biotec
Profit Margin (TTM)13.76%1.88%Titan Bio-Tech
Operating Margin (TTM)16.31%-5.74%Titan Bio-Tech
EBITDA Margin (TTM)16.31%N/AN/A
Return on Equity14.04%-1.01%Titan Bio-Tech
Return on Assets (TTM)12.32%-0.65%Titan Bio-Tech
Free Cash Flow (TTM)$106.79M$-776.74MTitan Bio-Tech
Dividend Yield0.42%N/AN/A
1-Year Return33.04%32.45%Titan Bio-Tech
Price-to-Sales Ratio (TTM)4.934.03Panacea Biotec
Enterprise Value$7.85B$23.69BPanacea Biotec
EV/Revenue Ratio4.913.88Panacea Biotec
Gross Profit Margin (TTM)48.49%53.68%Panacea Biotec
Revenue per Share (TTM)$193$100Titan Bio-Tech
Earnings per Share (Diluted)$26.62$1.86Titan Bio-Tech
Beta (Stock Volatility)0.230.36Titan Bio-Tech
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Titan Bio-Tech vs Panacea Biotec Stock Performance Analysis

Loading Price Chart...

Titan Bio-Tech
Panacea Biotec
Titan Bio-Tech Stock Overview | Panacea Biotec Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Titan Bio-Tech1.69%7.36%37.60%123.15%104.11%26.96%
Panacea Biotec1.16%-0.04%-2.22%-4.62%-10.01%-7.42%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Titan Bio-Tech33.04%252.87%522.82%3,129.33%2,862.69%5,150.95%
Panacea Biotec32.45%205.48%115.98%189.61%103.04%23.47%

News Based Sentiment: Titan Bio-Tech vs Panacea Biotec

Titan Bio-Tech

News based Sentiment: MIXED

September presented a mixed bag for Titan Biotech. While the company showcased impressive revenue growth and financial stability, the insider selling by a promoter raises concerns about confidence in the short-term outlook. This combination of positive and negative signals makes it a significant month for investors to assess the company's trajectory.

View Titan Bio-Tech News Sentiment Analysis

Panacea Biotec

News based Sentiment: MIXED

September presented a mixed bag for Panacea Biotec, with strong gains in some areas like vaccine development and product launches offset by conflicting financial reports and share price volatility. While the company is clearly making progress, the inconsistencies create uncertainty for investors, making this a significant but complex month.

View Panacea Biotec News Sentiment Analysis

Performance & Financial Health Analysis: Titan Bio-Tech vs Panacea Biotec

MetricTITANBIOPANACEABIO
Market Information
Market Cap i₹8.10B₹25.45B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i31,282183,458
90 Day Avg. Volume i32,475190,320
Last Close₹968.80₹406.90
52 Week Range₹373.65 - ₹1,017.00₹271.20 - ₹581.90
% from 52W High-4.74%-30.07%
All-Time High₹1,017.85 (Oct 21, 2024)₹581.90 (Apr 28, 2025)
% from All-Time High-4.82%-30.07%
Growth Metrics
Quarterly Revenue Growth0.08%0.44%
Quarterly Earnings Growth0.07%0.44%
Financial Health
Profit Margin (TTM) i0.14%0.02%
Operating Margin (TTM) i0.16%-0.06%
Return on Equity (TTM) i0.14%-0.01%
Debt to Equity (MRQ) i1.822.67
Cash & Liquidity
Book Value per Share (MRQ)₹185.75₹136.92
Cash per Share (MRQ)₹6.72₹17.95
Operating Cash Flow (TTM) i₹197.75M₹-1,511,860,000
Levered Free Cash Flow (TTM) i₹215.32M₹-83,700,000
Dividends
Last 12-Month Dividend Yield i0.42%N/A
Last 12-Month Dividend i₹4.00₹0.00

Valuation & Enterprise Metrics Analysis: Titan Bio-Tech vs Panacea Biotec

MetricTITANBIOPANACEABIO
Price Ratios
P/E Ratio (TTM) i35.79215.59
Forward P/E iN/AN/A
PEG Ratio i4.99-1.72
Price to Sales (TTM) i4.934.03
Price to Book (MRQ) i5.132.93
Market Capitalization
Market Capitalization i₹8.10B₹25.45B
Enterprise Value i₹7.85B₹23.69B
Enterprise Value Metrics
Enterprise to Revenue i4.913.88
Enterprise to EBITDA i30.03-188.13
Risk & Other Metrics
Beta i0.230.36
Book Value per Share (MRQ) i₹185.75₹136.92

Financial Statements Comparison: Titan Bio-Tech vs Panacea Biotec

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TITANBIOPANACEABIO
Revenue/Sales i₹464.96M₹1.67B
Cost of Goods Sold i₹239.50M₹772.20M
Gross Profit i₹225.47M₹894.80M
Research & Development iN/AN/A
Operating Income (EBIT) i₹75.85M₹-95.70M
EBITDA i₹94.59M₹44.90M
Pre-Tax Income i₹81.12M₹65.60M
Income Tax i₹19.51M₹26.00M
Net Income (Profit) i₹68.63M₹39.60M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TITANBIOPANACEABIO
Cash & Equivalents i₹51.28M₹821.25M
Total Current Assets i₹790.38M₹5.45B
Total Current Liabilities i₹177.36M₹3.67B
Long-Term Debt i₹4.19M₹150.00M
Total Shareholders Equity i₹1.53B₹8.31B
Retained Earnings i₹1.36B₹7.80B
Property, Plant & Equipment i₹571.62M₹5.43B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TITANBIOPANACEABIO
Operating Cash Flow i₹45.62MN/A
Capital Expenditures i₹-33.58MN/A
Free Cash Flow i₹12.24MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTITANBIOPANACEABIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i31,282183,458
Average Daily Volume (90 Day) i32,475190,320
Shares Outstanding i8.26M61.25M
Float Shares i2.65M15.45M
% Held by Insiders i0.67%0.73%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: Titan Bio-Tech vs Panacea Biotec

MetricTITANBIOPANACEABIO
Last 12-Month Dividend i₹4.00₹0.00
Last 12-Month Dividend Yield i0.42%N/A
3-Year Avg Annual Dividend i₹1.93₹0.00
3-Year Avg Dividend Yield i0.34%N/A
3-Year Total Dividends i₹5.80₹0.00
Ex-Dividend DateSep 19, 2025N/A